• Je něco špatně v tomto záznamu ?

Renal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease

S. Cormican, C. Kennedy, DM. Connaughton, P. O'Kelly, S. Murray, M. Živná, S. Kmoch, NK. Fennelly, KA. Benson, ET. Conlon, GL. Cavalleri, C. Foley, B. Doyle, A. Dorman, MA. Little, P. Lavin, K. Kidd, AJ. Bleyer, PJ. Conlon

. 2020 ; 34 (2) : e13783. [pub] 20200205

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020764

Grantová podpora
203930/B/16/Z Wellcome Trust - United Kingdom
NV17-29786A MZ0 CEP - Centrální evidence projektů

INTRODUCTION: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD). We aimed to compare renal transplant outcomes in people with ESRD due to ADTKD to those with other causes of renal failure. METHODS: Patients with clinical characteristics consistent with ADTKD by the criteria outlined in the 2015 KDIGO consensus were included. We compared ADTKD transplant outcomes with those of 4633 non-ADTKD renal transplant recipients. RESULTS: We included 31 patients who met diagnostic criteria for ADTKD in this analysis, 23 of whom had an identified mutation (28 were categorized as definite-ADTKD and 3 as suspected ADTKD). Five patients received a second transplant during follow-up. In total, 36 grafts were included. We did not identify significant differences between groups in terms of graft or patient survival after transplantation. Twenty-five transplant biopsies were performed during follow-up, and none of these showed signs of recurrent ADTKD post-transplant. CONCLUSION: In patients with ESRD due to ADTKD, we demonstrate that transplant outcomes are comparable with the general transplant population. There is no evidence that ADTKD can recur after transplantation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020764
003      
CZ-PrNML
005      
20210830102417.0
007      
ta
008      
210728s2020 dk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ctr.13783 $2 doi
035    __
$a (PubMed)31958169
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Cormican, Sarah $u Nephrology Department, Beaumont Hospital, Dublin, Ireland
245    10
$a Renal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease / $c S. Cormican, C. Kennedy, DM. Connaughton, P. O'Kelly, S. Murray, M. Živná, S. Kmoch, NK. Fennelly, KA. Benson, ET. Conlon, GL. Cavalleri, C. Foley, B. Doyle, A. Dorman, MA. Little, P. Lavin, K. Kidd, AJ. Bleyer, PJ. Conlon
520    9_
$a INTRODUCTION: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD). We aimed to compare renal transplant outcomes in people with ESRD due to ADTKD to those with other causes of renal failure. METHODS: Patients with clinical characteristics consistent with ADTKD by the criteria outlined in the 2015 KDIGO consensus were included. We compared ADTKD transplant outcomes with those of 4633 non-ADTKD renal transplant recipients. RESULTS: We included 31 patients who met diagnostic criteria for ADTKD in this analysis, 23 of whom had an identified mutation (28 were categorized as definite-ADTKD and 3 as suspected ADTKD). Five patients received a second transplant during follow-up. In total, 36 grafts were included. We did not identify significant differences between groups in terms of graft or patient survival after transplantation. Twenty-five transplant biopsies were performed during follow-up, and none of these showed signs of recurrent ADTKD post-transplant. CONCLUSION: In patients with ESRD due to ADTKD, we demonstrate that transplant outcomes are comparable with the general transplant population. There is no evidence that ADTKD can recur after transplantation.
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a lidé $7 D006801
650    12
$a chronické selhání ledvin $x chirurgie $7 D007676
650    12
$a transplantace ledvin $7 D016030
650    _2
$a mutace $7 D009154
650    12
$a polycystické ledviny autozomálně dominantní $7 D016891
650    _2
$a uromodulin $x genetika $7 D058949
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kennedy, Claire $u Nephrology Department, Beaumont Hospital, Dublin, Ireland $u Royal College of Surgeons, Dublin, Ireland
700    1_
$a Connaughton, Dervla M $u Nephrology Department, Beaumont Hospital, Dublin, Ireland $u Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland
700    1_
$a O'Kelly, Patrick $u Nephrology Department, Beaumont Hospital, Dublin, Ireland
700    1_
$a Murray, Susan $u Nephrology Department, Beaumont Hospital, Dublin, Ireland $u Royal College of Surgeons, Dublin, Ireland
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Fennelly, Neil K $u Pathology Department, Beaumont Hospital, Dublin, Ireland
700    1_
$a Benson, Katherine A $u Nephrology Department, Beaumont Hospital, Dublin, Ireland $u Royal College of Surgeons, Dublin, Ireland
700    1_
$a Conlon, Eoin T $u Nephrology Department, Beaumont Hospital, Dublin, Ireland
700    1_
$a Cavalleri, Gianpiero L $u Royal College of Surgeons, Dublin, Ireland
700    1_
$a Foley, Claire $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland $u Clinical Research Centre, Royal College of Surgeons, Dublin, Ireland
700    1_
$a Doyle, Brendan $u Pathology Department, Beaumont Hospital, Dublin, Ireland
700    1_
$a Dorman, Anthony $u Royal College of Surgeons, Dublin, Ireland $u Pathology Department, Beaumont Hospital, Dublin, Ireland
700    1_
$a Little, Mark A $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland $u Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland
700    1_
$a Lavin, Peter $u Trinity Health Kidney Centre, Tallaght Hospital, Dublin, Ireland
700    1_
$a Kidd, Kendrah $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Medical Centre Blvd., Winston-Salem, NC, USA
700    1_
$a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Medical Centre Blvd., Winston-Salem, NC, USA
700    1_
$a Conlon, Peter J $u Nephrology Department, Beaumont Hospital, Dublin, Ireland $u Royal College of Surgeons, Dublin, Ireland
773    0_
$w MED00001167 $t Clinical transplantation $x 1399-0012 $g Roč. 34, č. 2 (2020), s. e13783
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31958169 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102418 $b ABA008
999    __
$a ok $b bmc $g 1691357 $s 1141210
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 34 $c 2 $d e13783 $e 20200205 $i 1399-0012 $m Clinical transplantation $n Clin Transplant $x MED00001167
GRA    __
$a 203930/B/16/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a NV17-29786A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace